mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework

Messenger RNA (mRNA) therapeutics have emerged as a transformative platform following the success of COVID-19 vaccines.

Authors

Institutions

Publication Details

Journal
RSC Pharmaceutics
Published
2025-10-22
DOI
https://doi.org/10.1039/d5pm00159e
Citations
1
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework

Sarfaraz K. Niazi
1 citations
RSC Pharmaceutics
RNA Interference and Gene Delivery
0.81
article

mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework

Sarfaraz K. Niazi
article en
1 citations

Abstract

Messenger RNA (mRNA) therapeutics have emerged as a transformative platform following the success of COVID-19 vaccines.

RSC PharmaceuticsVol. 3(1)
University of Illinois Urbana-Champaign (US), University of Illinois Chicago (US)
Openalex Percentile: Top 22%
RNA Interference and Gene Delivery
0.81
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework — Sarfaraz K. Niazi · RSC Pharmaceutics (2025) | TGRS Research Map | TGRS